Aslıhan Zeynep ÖZ, Alper AKTAŞ, Hakan EL, Selen ADİLOĞLU

Hemostatic effects of adrenaline and Ankaferd (blood stopper) during orthodontic attachment bonding

Background/aim: Moisture prevention during the bonding of orthodontic attachments on impacted teeth is crucial for accomplishment.It was aimed to compare the hemostatic effects of adrenaline and Ankaferd Blood Stopper (ABS) during the surgical exposure of theimpacted maxillary canine.Materials and methods: The study consists of 20 patients, whose orthodontic treatments were outlined with the surgical exposure ofmaxillary impacted canine. Patients were divided into groups of 10; where each group was treated with one of the two medicines tocontrol bleeding. Group A was treated with adrenaline, and group B was treated with Ankaferd Blood Stopper (ABS). The bleedingperiod was recorded as the time from the exposure of the crown until the inception of bonding.Results: It was observed that both the bleeding period and the cumulative duration were significantly shorter in group B (the ABSgroup) than in group A (the adrenaline group) (P < 0.05), but no significant deviation in bonding times was recorded.Conclusion: ABS is a good alternative hemostatic agent for the prevention of bleeding at the surgical exposure of impacted teethwithout affecting the bonding.

PDF

___

Sayinsu K, Isik F, Sezen S, Aydemir B. Effect of blood and saliva contamination on bond strength of brackets bonded with a protective liquid polish and a light-cured adhesive. Am J Orthod Dentofac 2007; 131(3): 391-394.
Okşayan R, Sökücü O, İşman NE, Kayali KM, Cebe MA. Effects of hemostatic agents on shear bond strength of orthodontic brackets. Niger J Clin Pract 2015; 18(2): 189-193.
Karabekiroğlu S, Kök H. Do hemostatic agents affect shear bond strength and clinical bond failure rate of orthodontic brackets? J Adhes Sci Technol 2017; 32: 103-113.
Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251: 217-228.
Von Arx T, Jensen SS, Hänni S, Schenk RK. Haemostatic agents used in periradicular surgery: an experimental study of their efficacy and tissue reactions. Int Endod J 2006; 39: 800-808.
Loescher AR, Robinson PP. The effect of surgical medicaments on peripheral nerve function. Brit J Oral Max Surg 1998; 36: 327-332.
Pampu AA, Yildirim M, Tüzüner T, Baygin Ö, Abidin I, Dayisoylu EH, Senel FÇ. Comparison of the effects of new folkloric hemostatic agent on peripheral nerve function: an electrophysiologic study in rats. Or Surg Or Med Or Pa 2013; 115: e1-6.
Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 163-170.
İşler SC, Demircan S, Çakarer S, Çebi Z, Keskin C, Soluk M, Yüzbaşıoğlu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409-414.
Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H, Goker H, Kosar A, Aktas A, Captug O, Kurt M, Özdemir O et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb-Hem 2010; 16: 446-453.
Mihmanli A, Ulker Z, Alpsoy L, Ezirganli S. Evaluation of cytotoxicity of a new hemostatic agent Ankaferd Blood Stopper® using different assays. Hum Exp Toxicol 2012; 31: 780-787.
Bilgili H, Captug O, Kosar A, Kurt M, Kekilli M, Shorbagi A, Kurt OK, Ozdemir O, Goker H, Haznedaroglu IC. Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model. Clin Appl Thromb-Hem 2010; 16: 533-536.
Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010; 15: 329-336.
Aktas A, Er N, Kiris S, Koseoglu OT, Haznedaroglu IC. The Efficiency of Ankaferd Blood Stopper During the Dental Surgery in Hemorrhagic Diathesis: Case Series. Uhod-Uluslar Hematol 2014; 24: 60-64.
Baykul T, Alanoglu EG, Kocer G. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. The Journal of Contemporary Dental Practice 2010; 11: E088-94.
Dural Özalp E. Farmakoloji Genişletilmiş Üçüncü baskı, İstanbul, Türkiye: Nobel Tıp Kitabevleri Ltd Şti; 2002 (in Turkish).
Rodriguez-Cabrera MA, Barona-Dorado C, Leco-Berrocal I, Gomez-Moreno G, Martinez-Gonzalez JM. Extractions without eliminating anticoagulant treatment: a literature review. Med Oral Patol Oral 2011; 16: e800-804.
Bilgili H, Kosar A, Kurt M, Onal IK, Goker H, Captug O, Shorbagi A, Turgut M, Kekilli M, Kurt OK, Kirazli S, Aksu S, Haznedaroglu IC. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Prin Pract 2009; 18: 165-169.
Cipil HS, Kosar A, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Koroglu M, Kirazli S, Firat HC. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb-Hem 2009; 15: 270-276.
Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Ercetin S, Kirazli S, Firat HC. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a ratbleeding model. Blood Coagul Fibrin 2009; 20: 185-190.
Arslan S, Haznedaroglu IC, Öz B, Goker H. Endobranchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Resp Med 2008; 2: 144-146.
Dogan OF, Ozyurda U, Uymaz OK, Ercetin S, Haznedaroglu IC. New anticoagulant agent for CABG surgery. Eur J Clin Invest 2008; 38: 341-341.
Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. J Altern Complem Med 2008; 14: 1073-1074.
Kurt M, Disibeyaz S, Akdogan M, Sasmaz N, Aksu S, Haznedaroglu IC. Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol 2008; 103: 2156-2158.
Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008; 40 Suppl 2: E262.
Kandemir O, Buyukates M, Kandemir NO, Aktunc E, Gul AE, Gul S, Turan SA. Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model. J Cardiothorac Surg 2010; 5: 110.
Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhi 2009; 73: 1742- 1745.
Çakarer S, Eyüpoğlu E, Günes ÇÖ, Küseoğlu BG, Berberoğlu HK, Keskin C. Evaluation of the hemostatic effects of Ankaferd blood stopper during dental extractions in patients on antithrombotic therapy. Clin Appl Thromb-Hem 2013; 19: 96- 99.
Aktaş A, Er N, Korkusuz P, Zeybek D, Onur MA, Tan G, Özdemir O, Karaismailoğlu E, Karabulut E. Ankaferd-induced early soft tissue wound healing in an experimental rat model. Turk Klin Tıp Bilim 2013; 33: 1344-1353.
Kelles M, Kalcioglu MT, Samdanci E, Selimoglu E, Iraz M, Miman MC, Haznedaroglu IC. Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits. Current Therapeutic Research 2011; 72: 185-194.
Öztoprak MO, Isik F, Sayınsu K, Arun T, Aydemir B. Effect of blood and saliva contamination on shear bond strength of brackets bonded with 4 adhesives. Am J Orthod Dentofac 2007; 131: 238-242.
Trakyali G, Oztoprak MO. Plant extract ankaferd blood stopper effect on bond strength. Angle Orthod 2010; 80: 570-574.
Arslan S, Ertaş H, Zorba YO. Influence of Ankaferd Blood Stopper on shear bond strength of bonding systems. Dent Mater J 2012; 31: 226-231.